Although total tau (t-tau), phosphorylated tau (p-tau) and amyloid beta-42 (Aβ42) are state biomarkers of AD, some of the neuropathological changes observed in the brains of AD patients are not captured by these traditional biomarkers, such as α-syn inclusions “LBs”. Here, MAPT is linked to Alzheimer disease.